Food safety scientists have validated a new method to detect neurotoxins in seafood products using UHPLC–HILIC–MS/MS.
Photo Credit: stock.adobe.com/Yaruniv-Studio
Food safety scientists have validated a new method to detect neurotoxins in seafood products using ultrahighâpressure hydrophilic interaction liquid chromatography with tandem mass spectrometry (UHPLC–HILIC–MS/MS) (1). The international study was a joint fourâyear effort between the Centre for the Environment, Fisheries, and Aquaculture Science (Cefas), in the UK, and the Cawthron Institute, in New Zealand.
The method to detect toxins in bivalve mollusc shellfish, such as clams, mussels and oysters, was developed to include the highest range of paralytic shellfish poisoning (PSP) toxin analogues, symptoms of which include numbness of the mouth, vomiting, and in some cases death, as well as to address the emerging threat of tetrodotoxin, the toxin associated with fatalities from eating pufferfish.
“This new method gives the user the ability to detect more toxin analogues than any other detection method and also includes detection of tetrodotoxin. As such, it will be well suited to ensuring food safety is maintained well into the future,” said Andy Turner, Project Study Director and Principal Chemist in the Food Safety Group at Cefas.
The project was an international effort, incorporating 21 participating laboratories from five continents, 94 study materials utilized to prepare 34 study samples sourced from six continents, and 15 different shellfish species grown in areas impacted by all known species of PSP toxin-producing phytoplankton. The end result is a new protocol that reduces the labour required for analysis compared to current methods and also provides a higher accuracy and a shorter processing time.
“We’ve already realized the benefits of this testing method in New Zealand by providing our seafood industry with faster, more accurate results. This was particularly evident during two recent harmful algal bloom events where we were able to respond quickly to our industry partners to provide them with assurance their products were safe for market,” said Tim Harwood, Cawthron Institute Marine Toxin Chemist and New Zealand Seafood Safety Research Platform Leader.
Discussions will now start regarding the potential use of the method for future regulatory testing.
Reference
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.